Bay Street News, December, 2019

NOT FOR DISTRIBUTION IN THE U.S. OR OVER U.S. NEWSWIRESTORONTO, Dec. 02, 2019 (GLOBE NEWSWIRE) — NEW WAVE ESPORTS CORP. […]

VANCOUVER, British Columbia, Dec. 02, 2019 (GLOBE NEWSWIRE) — Gold Lion Resources Inc. (“Gold Lion” or the “Company”) (CSE: GL) is pleased […]

MIAMI, Dec. 02, 2019 (GLOBE NEWSWIRE) — NCL Corporation Ltd. (“NCLC”), a subsidiary of Norwegian Cruise Line Holdings Ltd. (NYSE:NCLH) […]

Rockville, MD, Dec. 02, 2019 (GLOBE NEWSWIRE) —MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing […]

~  Biorphen is the First and Only Ready-to-Use FDA-Approved Injectable Formulation of Phenylephrine ~~ Biorphen is Now Available for Order Through […]

HIGH POINT, N.C., Dec. 02, 2019 (GLOBE NEWSWIRE) — vTv Therapeutics Inc. (Nasdaq: VTVT), a clinical-stage biopharmaceutical company focused on […]

WARREN, N.J., Dec. 02, 2019 (GLOBE NEWSWIRE) — Aquestive Therapeutics, Inc. (NASDAQ:AQST), a specialty pharmaceutical company focused on developing and […]

Neurocrine Biosciences Gains Rights to XEN901, a Clinical Stage Selective Nav1.6 Sodium Channel Inhibitor, Being Developed for the Treatment of […]

            Curetis Expects Near-Term U.S. FDA Decision on 510(k) Clearance of Unyvero LRT for BAL Specimens  […]

SAN DIEGO and TORONTO, Dec. 02, 2019 (GLOBE NEWSWIRE) — Aptose Biosciences Inc. (NASDAQ: APTO; TSX: APS), a clinical-stage company […]